JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis

Abstract New hematopoietic cell models have recently emerged through immortalization of CD34 cells to study and understand various molecular mechanisms of erythropoiesis. Here, we characterize the JK-1 CML-derived cell line, previously shown to spontaneously differentiate without cytokines. Using an...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvain Metral, Sandrine Genetet, Benoît Gamain, Isabelle Mouro-Chanteloup
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-76897-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544561512415232
author Sylvain Metral
Sandrine Genetet
Benoît Gamain
Isabelle Mouro-Chanteloup
author_facet Sylvain Metral
Sandrine Genetet
Benoît Gamain
Isabelle Mouro-Chanteloup
author_sort Sylvain Metral
collection DOAJ
description Abstract New hematopoietic cell models have recently emerged through immortalization of CD34 cells to study and understand various molecular mechanisms of erythropoiesis. Here, we characterize the JK-1 CML-derived cell line, previously shown to spontaneously differentiate without cytokines. Using an epigenetic differentiation inhibitor that keeps JK-1 in an early differentiation phase, we characterized 2 progenitor stages: BFU-E JK-1 and CFU-E JK-1 with CD34+/CD36− and CD34−/CD36 + phenotypes respectively. Then, using the PFI-1 inducer known to synchronously control the terminal differentiation of JK-1 cells, 5 precursor stages were obtained (ProE, Baso1-2, PolyC, OrthoC) and characterized via cell morphology, CD49a and Band3 markers. Enlarged phenotyping was carried out for the earlier phase, and expression kinetics of membrane proteins such as RhAG, RhD/CE, CD47, DARC and CD44 were performed on each stage of the terminal phase. Furthermore, since JK-1 offers the unique property of covering a broad spectrum of differentiation stages, we explored deeper the GATA2/GATA1 and the non-erythroid/erythroid spectrin ‘switching’. The possibility of obtaining large quantities of JK-1 cells at each stage of differentiation, as shown in this study, as well as the potential to genetically modify these cells, via CrisprCas9, makes their use of considerable interest for studying pathologies occurring during erythropoiesis.
format Article
id doaj-art-0bdf975c154947b18140547ea6c60d39
institution Kabale University
issn 2045-2322
language English
publishDate 2024-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-0bdf975c154947b18140547ea6c60d392025-01-12T12:24:54ZengNature PortfolioScientific Reports2045-23222024-10-0114111110.1038/s41598-024-76897-7JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesisSylvain Metral0Sandrine Genetet1Benoît Gamain2Isabelle Mouro-Chanteloup3Université Paris Cité and Université des Antilles, Inserm U1134, BIGRUniversité Paris Cité and Université des Antilles, Inserm U1134, BIGRSorbonne Université, Inserm U1135, CNRS ERL 8255Sorbonne Université, Inserm U1135, CNRS ERL 8255Abstract New hematopoietic cell models have recently emerged through immortalization of CD34 cells to study and understand various molecular mechanisms of erythropoiesis. Here, we characterize the JK-1 CML-derived cell line, previously shown to spontaneously differentiate without cytokines. Using an epigenetic differentiation inhibitor that keeps JK-1 in an early differentiation phase, we characterized 2 progenitor stages: BFU-E JK-1 and CFU-E JK-1 with CD34+/CD36− and CD34−/CD36 + phenotypes respectively. Then, using the PFI-1 inducer known to synchronously control the terminal differentiation of JK-1 cells, 5 precursor stages were obtained (ProE, Baso1-2, PolyC, OrthoC) and characterized via cell morphology, CD49a and Band3 markers. Enlarged phenotyping was carried out for the earlier phase, and expression kinetics of membrane proteins such as RhAG, RhD/CE, CD47, DARC and CD44 were performed on each stage of the terminal phase. Furthermore, since JK-1 offers the unique property of covering a broad spectrum of differentiation stages, we explored deeper the GATA2/GATA1 and the non-erythroid/erythroid spectrin ‘switching’. The possibility of obtaining large quantities of JK-1 cells at each stage of differentiation, as shown in this study, as well as the potential to genetically modify these cells, via CrisprCas9, makes their use of considerable interest for studying pathologies occurring during erythropoiesis.https://doi.org/10.1038/s41598-024-76897-7ErythropoiesisProgenitorPrecursorJK-1 cellsExpression switching
spellingShingle Sylvain Metral
Sandrine Genetet
Benoît Gamain
Isabelle Mouro-Chanteloup
JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
Scientific Reports
Erythropoiesis
Progenitor
Precursor
JK-1 cells
Expression switching
title JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
title_full JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
title_fullStr JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
title_full_unstemmed JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
title_short JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
title_sort jk 1 a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis
topic Erythropoiesis
Progenitor
Precursor
JK-1 cells
Expression switching
url https://doi.org/10.1038/s41598-024-76897-7
work_keys_str_mv AT sylvainmetral jk1ausefulerythroleukemiccelllinemodeltostudyacontrollederythroiddifferentiationfromprogenitorstoterminalerythropoiesis
AT sandrinegenetet jk1ausefulerythroleukemiccelllinemodeltostudyacontrollederythroiddifferentiationfromprogenitorstoterminalerythropoiesis
AT benoitgamain jk1ausefulerythroleukemiccelllinemodeltostudyacontrollederythroiddifferentiationfromprogenitorstoterminalerythropoiesis
AT isabellemourochanteloup jk1ausefulerythroleukemiccelllinemodeltostudyacontrollederythroiddifferentiationfromprogenitorstoterminalerythropoiesis